Astro-Med Product Selected for New Video-EEG Applications

EC2 is a proprietary formulation of electrolyte cream thatGrass-Telefactor has been manufacturing and selling for many years. Itis a consumable product that is used not only in long-term video-EEGapplications, but also for routine EEG, Sleep and Neuromonitoringstudies. In long-term video-EEG applications, it has been necessary touse a collodian (a highly flammable glue that contains alcohol andether) to better secure the electrodes for the several days or week ofmonitoring. The collodian tends to irritate the patient's skin andmany labs, especially in Europe, are beginning to ban the substance.As a result, a team of clinicians in Italy performed a patient studyto find a safe alternative to the collodian.

The study was performed at Neuromed, a hospital in the Naples areaof Italy, by a team of clinicians at their video-EEG laboratory. Atotal of 40 patients with drug resistant partial epilepsy participatedin the study. In 20 patients, electrode placement on the scalp wasmade with collodian and on the remaining 20 patients EC2 was used. Theresults confirmed better electrical signal quality, fasterapplication, and more patient comfort and safety with the EC2.

The study was published in the Official Journal of theInternational Federation of Clinical Neurophysiology, entitledClinical Neurophysiology, Volume 116, Issue 8, dated August, 2005.Clinical Neurophysiology is published by Elsevier Limited, a largeEuropean publishing firm.

The Company expects sales of EC2 to increase substantially as aresult of the new study. EC2 is one of many consumable suppliesmanufactured by Grass-Telefactor, and is sold hand in hand with thefamous Genuine Grass Gold Cup Electrodes for EEG and Sleepapplications.

Astro-Med, Inc. is a leading manufacturer of test and measurementinstruments, high tech specialty printing systems and electronicmedical instrumentation employed around the world in a wide range ofindustrial, scientific and medical applications.

Safe Harbor Statement

This news release contains forward-looking statements, and actualresults may vary from those expressed or implied herein. Factors thatcould affect these results include those mentioned in Astro-Med'sFY2005 annual report and its annual and quarterly filings with theSecurities and Exchange Commission.